Kenvue Inc. logo

Kenvue Inc. (KVUE)

Market Closed
9 Jun, 20:00
NYSE NYSE
$
17. 92
+0.37
+2.1083%
$
34.41B Market Cap
21.62 P/E Ratio
0.83% Div Yield
17.25M Volume
1.14 Eps
$ 17.55
Previous Close
Add Transaction
Day Range
17.44 17.94
Year Range
14.02 22.87
Want to track KVUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
53 July Dividend Kings: Buy 8, Watch 8 More

53 July Dividend Kings: Buy 8, Watch 8 More

"What is a Dividend King? A stock with 50 or more consecutive years of dividend increases."—suredividend.com. The 53 Dividend Kings, screened as of July 8, represented 8 of 11 Morningstar Sectors. Broker-targeted top-ten net-gains ranged 18.24%-30.31% topped-by Kenvue, and Genuine Parts. By yield, Altria tops-all. Top-ten July listings: SWK, FRT, KVUE, FTS, UBSI, BKH, NWN, CDUAF, UVV, MMM, & MO averaged 5.37% in yield.

Seekingalpha | 1 year ago
Kenvue: Portfolio Of Products Can Be Replaced With Generic Brands

Kenvue: Portfolio Of Products Can Be Replaced With Generic Brands

Kenvue (KVUE) was created as the result of a spinoff from Johnson & Johnson and encompasses the consumer side of the business. KVUE manages a wide array of products within each segment, but sales volume remains vulnerable to consumer spending. Data shows us that consumers are willing to go with store-branded generics as an alternative to name brands under KVUE's umbrella to save money.

Seekingalpha | 1 year ago
3 Healthcare Stocks to Buy Now: May 2024

3 Healthcare Stocks to Buy Now: May 2024

It's a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the overall stock market by an average of 10% over the past seven recessions.

Investorplace | 2 years ago